Please login to the form below

Not currently logged in
Email:
Password:

CMA

This page shows the latest CMA news and features for those working in and with pharma, biotech and healthcare.

AZ seeks EU approval for its Oxford University-partnered COVID-19 vaccine

AZ seeks EU approval for its Oxford University-partnered COVID-19 vaccine

The EMA announced today that it had received an application for conditional marketing authorisation (CMA) for AZ/Oxford’s COVID-19 vaccine. ... In December 2020, the EC also authorised a CMA for Pfizer/BioNTech’s COVID-19 vaccine, now known as

Latest news

  • UPDATED: EU authorises Pfizer/BioNTech's COVID-19 vaccine UPDATED: EU authorises Pfizer/BioNTech's COVID-19 vaccine

    Authorisation closely follows CHMP recommendation. The European Commission has granted Pfizer/BioNTech's COVID-19 vaccine a conditional market authorisation (CMA) on the same day that the European Medicines Agency's ... Under the CMA process, the

  • Moderna eyes COVID-19 vaccine approval in the US and the EU Moderna eyes COVID-19 vaccine approval in the US and the EU

    The company is also set to apply for a Conditional Marketing Authorisation (CMA) application with the European Medicines Agency (EMA), priming itself to score regulatory approval for the vaccine on both

  • Roche to close $4.3bn Spark deal after FTC clearance Roche to close $4.3bn Spark deal after FTC clearance

    The main concern posed by the CMA and the FTC is that the newly merged company could have an overly dominant position in the haemophilia A market. ... The FTC and CMA investigation into the merger was a surprise for not only Spark, but the entire pharma

  • UK’s CMA clears Roche’s $4.3bn takeover of Spark UK’s CMA clears Roche’s $4.3bn takeover of Spark

    Roche first announced its intention to acquire Spark in February, but has had to keep pushing back the completion date as the FTC in the US and the CMA in the ... In a statement from the CMA, the antitrust authority said: “While gene therapy treatments

  • Pfizer, Flynn face reinstatement of £90m CMA fine Pfizer, Flynn face reinstatement of £90m CMA fine

    The case dates back to 2015, when the Competition and Markets Authority (CMA)   accused the two companies of dramatically raising the price of phenytoin sodium, a drug that has been used ... A  report in the Financial Times says the CMA is arguing

More from news
Approximately 5 fully matching, plus 13 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics